Ascletis Pharma IPO Preview: Drug-Fuelled Euphoria Needed to Justify Valuation
Ascletis Pharma Inc (AP HK) which specialises in developing drugs to treat HCV (hepatitis C virus), HIV and liver cancer, is the first pre-profit...
736 Views
Legend's Conversion of Domestic Shares
Yesterday, a CCASS filing highlighted 850mn shares entering Legend Holdings Corp H (3396 HK)'s share registry via CCASS Participant ID A00002, as...
311 Views
Quiddity Weekly H/A: Discounts & Southbound Flows 20180126
This is a new H/A Spread monitor project offering a brief look at recent changes in H-Share and A-Share spreads, Southbound flow and impact, and...
363 Views
Inventory Growth > COGS Growth for 4 Years Now for Livzon Pharm
Joincare (600380.CH) is a controlling shareholder of Livzon and also is the top supplier for Livzon. What does it do to the inventory growth in...
313 Views
Falling Fertility Adds to China's Population Woes
By allowing couples to have up to two children China hopes to reverse its likely population decline. But falling fertility and the pressures of...
4.1k Views